Novartis says buys Ziarco Group to expand skin care portfolio

ZURICH (Reuters) - Novartis is buying privately held drugmaker Ziarco Group for an undisclosed sum to gain access to its investigational eczema medicine, the Swiss pharmaceutical giant said on Friday.